HealthcareServices

Genetic Testing Market Insights Report: Opportunities and Drivers 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Genetic Testing Market between 2026 and 2030?

The genetic testing market has experienced robust expansion in recent years. Forecasts indicate its size will grow from $20.84 billion in 2025 to $22.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. Historically, this market’s growth has been driven by advancements in molecular biology, declining DNA sequencing costs, heightened awareness of genetic disorders, the expansion of diagnostic laboratories, and its early adoption in oncology.

The genetic testing market is anticipated to experience substantial growth in the coming years. It is projected to expand to $32.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.9%. This projected growth throughout the forecast period stems from the advancement of personalized medicine, the incorporation of genetic data into clinical decisions, the escalating burden of chronic diseases, the expansion of preventive healthcare, and improvements in genetic counseling services. Furthermore, significant trends expected during this period include a greater adoption of predictive genetic testing, the increasing application of prenatal and newborn screening, a rising demand for pharmacogenomics testing, the broadening scope of cancer genetic diagnostics, and enhanced availability of direct-to-consumer genetic tests.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6729&type=smp

Which Drivers Are Expected To Impact The Genetic Testing Market During The Forecast Period?

The increasing occurrence of genetic disorders is anticipated to drive the expansion of the genetic testing market in the future. Genetic disorders are conditions that manifest symptoms either at birth or develop later in life. Through genetic testing, individuals can obtain a diagnosis for genetic problems and insights into their risk of developing cancer. For example, data from 2024, as per a World Health Organization report, a Switzerland-based Intergovernmental organization, indicates that genetic disorders and congenital abnormalities impact 2%-5% of live births, contribute to 30% of pediatric hospital admissions, and are responsible for approximately 50% of childhood deaths in industrialized countries. Consequently, the growing incidence of genetic disorders is a key factor propelling the genetic testing market.

Which Segments Are Driving Activity In The Genetic Testing Market?

The genetic testing market covered in this report is segmented –

1) By Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types

2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing

3) By Application: Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications

4) By End User: Hospitals And Clinics, Diagnostic Laboratories And Centres, Other End Users

Subsegments:

1) By Predictive Testing: Genetic Risk Assessment, Family History-Based Testing

2) By Carrier Testing: Single Gene Carrier Testing, Expanded Carrier Screening

3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Newborn Screening Tests

4) By Diagnostic Testing: Confirmatory Genetic Testing, Clinical Diagnostic Testing

5) By Pharmacogenomics Testing: Drug Response Testing, Adverse Drug Reaction Testing

6) By Nutrigenomic Testing: Dietary Response Testing, Metabolism Testing

7) By Other Types: Ancestry Testing, Whole Genome Sequencing

What Trends Are Reshaping The Dynamics Of The Genetic Testing Market?

Leading companies within the genetic testing market are concentrating on developing advanced solutions, such as AI-driven genomic interpretation algorithms, to address the increasing demand for improved variant categorization, enhanced diagnostic precision, and greater inclusivity in precision healthcare. AI-based genomic interpretation tools analyze extensive genetic datasets to identify pathogenic variants more efficiently than traditional manual or rule-dependent methods, offering quicker insights, reduced uncertainty, and superior predictive accuracy in genetic testing. For instance, in June 2023, Illumina, Inc., a U.S.-based biotechnology and medical equipment company, unveiled PrimateAI-3D, a novel artificial intelligence algorithm designed to predict disease-causing genetic mutations. This tool utilizes a three-dimensional structural understanding of proteins and evolutionary comparisons among primate species to prioritize potentially pathogenic variants. It enhances large-scale genomic interpretation, accelerates precision medicine, and refines diagnostic workflows by empowering researchers and clinicians to assess genetic risk with greater accuracy. PrimateAI-3D supports the faster, more reliable detection of clinically relevant mutations, ultimately fortifying genetic testing capabilities.

Which Major Firms Are Strengthening Their Position In The Genetic Testing Market?

Major companies operating in the genetic testing market are Myriad Genetics Inc, Illumina Inc, Abbott Laboratories, Eurofins Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Qiagen NV, Thermo Fisher Scientific Inc., BioRad Laboratories Inc., BGI, Berry Genomics Co. Ltd, Daan Gene Co. Ltd, Annoroad Gene Technology Co. Ltd, Igenomix, Circle DNA, Centogene, Probably Genetic, Genome Biologics, WuXi NextCODE, Genomtec, Testgene, Evogen Lab, Phosphorus, Helix, 10x Genomics, Quantgene, DNALabs, Deep Genomics, Hologic Inc, Molecular Biology & Genetics Laboratory, IVI MIDDLE EAST FERTILITY CLINIC, Bio Certica

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Genetic Testing Market?

North America was the largest region in the genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6729&type=smp

Browse Through More Reports Similar to the Global Genetic Testing Market 2026, By The Business Research Company

Prenatal And Newborn Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Genetic Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Dna Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795